ICON expects market conditions to remain similar through year-end, assuming persistent cancellation rates and mixed timing on biotech conversions. The company raised its full year revenue guidance to ...

Full-year revenue guidance was updated to a new range of $7.85 billion at the low end and $8.15 billion at the high end, "increasing the midpoint to $8 billion." The full-year adjusted earnings per ...

Earnings Call Insights: ICON Public Limited Company (ICLR) Q3 2025 Steven Cutler reflected on his tenure, noting ICON's growth from 8,500 to 40,000 employees and its rise in industry ranking. He ...